Data from Mouth Cancer.org - Curated by EPG Health - Date added 23 November 2017

November is Mouth Cancer Action Month. Mouth cancer can affect the lips, cheeks, throat and tongue, and can affect anyone. Mouth cancers are most prevalent in people over the age of 40 (men in particular). 7.000 patients were diagnosed with mouth cancer last year in the UK alone (an increase of more than a third compared to 10 years ago) and women and younger patients are being diagnosed more frequently.

Signs of mouth cancer include painless mouth ulcers, white or red patches, unusual lumps and swellings. Tobacco and alcohol are linked to most cases of mouth cancer, with chewing tobacco, betel quid, gutkha and paan considered particular risks.

Mouth Cancer Action Month organisers, the Oral Health Foundation, are encouraging the message that:

  • It is important to see a dentist regularly (even if dentures are worn)
  • When brushing your teeth, look for signs of change
  • Use a suitable SPF sun cream to protect lips
  • Adhere to a healthy diet rich in vitamins A, C and E
  • Limit smoking and alcohol consumption

Message from the organisers to healthcare and dental professionals:

'Mouth cancer is at the forefront of the dental and health profession and Mouth Cancer Action relies on your participation and involvement to get our messages out into local communities. Last year, around 1,500 dental practices, hospitals, GPs and pharmacies took part in the campaign, helping us to deliver messages of healthy lifestyles, early detection and prevention to millions. Once again, we urge you to help raise awareness of mouth cancer. Taking part in Mouth Cancer Action is easy.  It doesn’t necessarily involve lots of time or money, just the passion to make a difference and help promote oral health in your community.'

Supporters can help by participating in the thunderclap for Mouth Cancer Action month:

 

 

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Biosimilars in Oncology Knowledge Centre

Biosimilars in Oncology Knowledge Centre

What are biologics and how do they differ from small molecule medicines? Discover more about their development, as well as the manufacturing and regulatory processes in the Biosimilars in Oncology Knowledge Centre.

Load more

Related Content